Figure 3
From: Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter
HIV-1 latency over time. AB: SupT1 T cells were infected with HIV-1LAI. On day 2, 7 and 14 the culture was split and either mock treated, induced with anti-latency drugs (TNFα or Vorinostat) or passaged and cultured for another week, when the protocol was repeated. Cells were harvested 24 hours after treatment (day 3, 8 and 15 respectively). Percentages of CA-p24 positive cells were determined by FACS. CD: The fold activation from latency. The results presented reflect the average of two independently produced virus stocks, and each was used in two independent infections.